Rebecca Siegel doesn't usually pay attention to one-year drops in data trends, but the 2.2% decline in overall cancer mortality from 2016 to 2017—driven primarily by lung cancer—seemed too big to ignore.
On Feb. 1, Thomas J. Lynch will report to work as president and director of Fred Hutchinson Cancer Research Center.
Contrary to declarations by Moffitt Cancer Center, Thomas Sellers, the institution's ousted director, was not involved in the Thousand Talents program sponsored by the People's Republic of China, said a Florida attorney who represents Sellers in preparing a lawsuit against the cancer center.
Consider these data points on cancer disparities:
We asked the leadership of 10 companies to share their visions of the future of data sharing, describe their portfolios in real-world evidence, and opine on what it would take to convince FDA accept real-world endpoints in regulatory decision-making in oncology.
If real-world endpoints are indeed accurate proxies for clinical trial endpoints, real-world endpoints should start to look increasingly similar to the clinical trial endpoints as more stringent criteria are applied, said Jeff Allen, president and CEO of Friends of Cancer Research.
As one of the cancer hospitals serving Los Angeles County, the UCLA Jonsson Comprehensive Center has to face the challenge of providing the most sophisticated—and most expensive—care to a largely underserved population.
William Kaelin and Gregg Semenza have a message for young scientists: do science for its own sake—and enjoy it.
David H. Thompson, a professor at the Department of Chemistry at Purdue University and a member of the Purdue Center for Cancer Research, is working on a better and faster way to produce drugs and eliminate shortages.
By allowing cancer centers to extend their Cancer Center Support Grant award period from five to seven years, NCI hopes to enable eligible centers to spend less time preparing for a grant renewal in favor of conducting more research and setting long-term goals.
